ARM A Type of group

6 trials

Sponsors

EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),, COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS - CIPRA,, TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.,, Instituto Nacional de Salud de los EE.UU (NIH-US),, HOSSIER ONCOLOGY GROUP,

Unknown Phase

RANDOMIZED STUDY OF PHASE I / II OF TRASTUZUMAB (HERCEPTIN) AND ZD1839 (IRESSA) IN PATIENTS WITH CANCER OF MASSASTASICO ON EXPRESSING HER 2 POSITIVE

Active, not recruitingPER-075-03

EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),

Target: 5Updated: 2023-09-04

EFFECT ON THE FREQUENCY OF CONVULSIVE CRISES OF THE REINFORCED DOSAGE OF CORTICOIDS IN THE TREATMENT OF INTRAPARENQUIMAL NEUROCYSTICERCOSIS

Active, not recruitingPER-075-05

Instituto Nacional de Salud de los EE.UU (NIH-US),

Updated: 2023-09-04

PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE CHEMOTHERAPY FOR BREAST CANCER, CORRELATIVE STUDY OF GENOMICS, PROTEOMICS AND PHARMACOGENOMY

Active, not recruitingPER-079-05

HOSSIER ONCOLOGY GROUP,

Start: 2005-11-01Target: 160Updated: 2023-09-04

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

Active, not recruitingPER-011-06

EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),

Start: 2006-05-26Target: 15Updated: 2023-09-04

Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia

Active, not recruitingPER-024-06

TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.,

Start: 2006-08-16Target: 72Updated: 2023-09-04

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Active, not recruitingPER-017-06

COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS - CIPRA,

Start: 2006-09-04Target: 50Updated: 2023-09-04